Recruiting NA INTERVENTIONAL 2-arm NCT06611098

New Treatment of Knee Osteoarthritis (PIVHAC)

A Randomized, Controlled, Prospective and Multicenter Clinical Investigation Evaluating the Safety and Performance of ABIO3419 in Treating Knee Osteoarthritis.

Sponsor: Symatese

Conditions Knee Osteoarthristis

Interventions Viscosupplements

Updated 3 times since 2024 Last updated: Feb 24, 2025 Started: Feb 21, 2025 Primary completion: Sep 30, 2025 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Knee Osteoarthristis, this trial is actively recruiting participants. The trial is conducted by Symatese and has accumulated 3 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Mar 2025 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Mar 2025 [monthly]

Not Yet Recruiting NA
Oct 2024 — Nov 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Symatese

Data source: Symatese

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mtskheta, Georgia
• Riga, Latvia